Aug 26, 2025
21:20
For every 20 shares held, investors received 21. The price per share adjusted from $33.70 to $32.10.
The split itself did not change the total investment value.
Chi Sheng Pharma & Biotech Co., Ltd. (TPEX:4111) operates in the Pharmaceuticals: major industry.
Chi Sheng Pharma & Biotech Co., Ltd. company overviewChi Sheng Pharma & Biotech Co., Ltd.'s most recent stock split was on August 26, 2025. It was a 21-for-20 forward split, so shareholders received 21 shares for every 20 they held.
Chi Sheng Pharma & Biotech Co., Ltd. (TPEX:4111) has split its stock 8 times: a 21-for-20 split on September 13, 2005, a 41-for-40 split on September 19, 2006, a 41-for-40 split on September 2, 2010, a 51-for-50 split on September 1, 2011, a 26-for-25 split on September 4, 2013, a 21-for-20 split on August 28, 2014, a 26-for-25 split on September 17, 2015, and a 21-for-20 split on August 26, 2025.
Chi Sheng Pharma & Biotech Co., Ltd. has split its stock 8 times. This history records 8 forward splits between September 13, 2005 and August 26, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Chi Sheng Pharma & Biotech Co., Ltd.'s 21-for-20 split on August 26, 2025, every 20 shares became 21 shares.
Chi Sheng Pharma & Biotech Co., Ltd. has not announced a new split in our records. Its most recent split was on August 26, 2025, 1 year ago. Companies announce splits in advance, and any new TPEX:4111 split will appear on this page.
Already premium?